Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity

Annals of Internal Medicine

Volumn 126, Issue 1, 1997, Pages 26-31

  Rönnemaa, Tapani ^a   Karonen, Sirkka Liisa ^a   Rissanen, Aila ^a   Koskenvuo, Markku ^a   Koivisto, Veikko A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; ARTICLE; BODY FAT; CONTROLLED STUDY; FEMALE; FINLAND; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; OBESITY; PRIORITY JOURNAL; SATIETY; SEX DIFFERENCE; TWIN DISCORDANCE;

EID: 0031026234     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-1-199701010-00004     Document Type: Article

References (26)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
2. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, et al. Effect of the obese gene product on body weight regulation in oblob mice. Science. 1995;269:540-3.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al. Weitht-reducing effect of the plasma protein encoded by the obese gene science. 1995;269:540-3.
4. weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, et al. Recombinant ob protein reduces feeding and body weight in the oblob mouse. J Clin Invest. 1995;96:2065-70.
5. Considine RV, Considine EL, Williams CJ, Nyce MR, Magosin SA, Bauer TL, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest. 1995;95:2986-8.
6. Maffei M, Halaas J, Rauvussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-61.
7. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
8. Stephens TW, Basinki M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 1995;377:530-2.
9. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM. Leptin enters the brain by a saturable system independent of insulin. Peptides. 1996;17:305-11
10. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996;348:159-61.
11. Cusin I, Sainsbury A, Doyle P. Rohner-Jeanrenaud F, Jeanrenaud B. The ob gene and insulin. A relationship leading to clues to the understanding of obesity. Diabetes. 1995;44:1467-70.
12. Kissebah A, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54:254-60.
13. Evans DJ, Hoffmann RG. Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensrtivity and metabolic profiles in premenopausal women. Metabolism. 1984;33:68-75.
14. Bjötorp P. Portal adipose tisue as a generator of risk factors for cardiovascular disease and diabetes. arteriosclerosis. 1990;10:493-6.
15. Kaprio J, Sarna S, Koskenvuo M, Rantsalo I. the Finnish Twin Registry formation and compliation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res. 1978;24 pt B;179-84.
16. Sarna S, Kaprio J, Sistonen P, Koskenvuo M. Diagnosis of Twin Zygosity by mailed questionnaire. Hum Hered. 1978;28241-54.
17. Smith SM, Penrose LS. Monozygotic and dizygotic twin analysis. Ann Human Gen. 1995;19:273-89.
18. Redd T. Blind assesment of zygosity using dermatoglyphics fro the NHLBI twin study. American Dermatoglyphics Association Newsletter. 1986;5:6-11.
19. Heymsfield SB, Lichtman S, Baumgartner RN, Want J, Kamen Y, Aliprantis A, et al. Body composition of humans: comparision of two improved four-compartment models that differ in expense, technical complexity, and radiation expousure. Am J Clin Nutu. 1990;52-52-8.
20. Baumgartner RN, Chumlea WC, Roche AF. Bioelectric impedance for body composition. Exerc Sprot Sci Rev. 1990;18-139-224.
21. Siri WE. The gross composition of the body. In: Advances in Biological and Medical Physics New York: Academic Pr; 1956:239-80.
22. Staten MA. Totty WG, Kohrt WM. Measurement of fat distribution by magnetic resonance imaging. Invest Radiol. 1989;24:345-9.
23. Despres JP, Moorjani S, Lupien PJ, tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. arteriosclerosis. 1990;10:497-511.
24. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994;74:761-811.
25. Lönnqvist F, Arner P, Nordfors L, Schalling M. Overexpression of the obse (ob) gene in adipose tissue of human obese subjects. Nat Med. 1995;1:950-3.
26. Abate N, Gart A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men J Clin Invest. 1995;96:88-98.